United States

The Province of Alberta came to market on Tuesday for a five year dollar global bond, paving the way for the Swedish Export Credit Corporation (SEK), which announced that it will hit the three year bucket on Wednesday.

Shanghai Fosun Pharmaceutical Group, which bought Indian company Gland Pharma in 2016, is planning to list the subsidiary on the National Stock Exchange of India and the BSE.

In this round-up, the US and China held another round of phone calls on trade last Friday, China officially launched the 5G mobile network and the rise in Caixin Purchasing Managers’ Index (PMI) was at odds with the slump in the official PMI.

In this round-up, the Chinese Communist Party (CCP) said it will strengthen the country’s ideological and institutional design, the Chilean government called off a planned Apec meeting and the State Administration for Market Regulation (SAMR) and the People’s Bank of China released a list of certified fintech products.

UBS lets go of ECM bankers — Bank of America’s Coben to return after Twitter investigation — Macquarie closes cash equities business in Europe and US

HSBC is planning to allocate capital away from lower return operations, including the global banking and markets (GBM) division in certain regions, as interim chief executive Noel Quinn revealed disappointing third quarter results on Monday.

Dollar volumes proved higher than expected as the US investment grade market roared back to life following earnings blackouts, with a string of front-loaded deals ahead of the Fed’s meeting on Wednesday.

French auto-manufacturer PSA Group, which owns Peugeot, and Fiat Chrysler Automobile's (FCA) decision to explore a merger to create the world’s fourth largest car company is an important marker for an industry facing an uncertain future as sustainability and the environment become global priorities.

Dechra Pharmaceuticals, the UK veterinary pharmaceuticals company, has entered the US private placement (US PP) market, according to sources, in a debut set to test institutional appetite for the sector.

Chinese biopharmaceutical firm I-Mab has set the ball rolling for a potential $100m Nasdaq IPO, having filed a prospectus with the US regulator on Tuesday.

The Bank of Japan appears to have softened its stance on the country’s banks buying foreign CLOs, reporting that credit risk in the asset class is “subdued on the whole” following a slowdown in investment in the asset class.

Equity capital markets bankers are hoping that recent market optimism, driven by hopes of a trade accord between the US and China, will provide a positive backdrop in which to do accelerated transactions before the end of the year.